Lennon David James 4

What Happened
Lennon David James, Chief Executive Officer of Whitehawk Therapeutics, sold 14,500 shares on April 9, 2026. The shares were sold at $3.38 each for total proceeds of $49,010. This was a sale (not a purchase) and appears to be a routine, non-investment sale tied to equity compensation.

Key Details

• Transaction date: 2026-04-09
• Price per share: $3.38; total proceeds: $49,010
• Transaction type/code: Sale (S) — broker-assisted sale
• Footnote: Broker-assisted sale to satisfy the reporting person’s tax withholding obligations in connection with the vesting of restricted stock units (RSUs) (Footnote F1).
• Shares owned after transaction: Not disclosed in this filing.
• Filing: Form 4 filed 2026-04-10 (appears timely; no late filing indicated).

Context
Broker-assisted sales to cover tax withholding for vested RSUs are common and generally considered routine compensation-related transactions rather than a direct signal about the insider’s view of the company’s stock.